SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Hematology/Oncology

[Return To Index page]
photo Darcy L. Thull, MS

Instructor, Department of Medicine

Genetic Counselor, UPMC Cancer Genetics Program

Email: dthull@magee.edu

Phone: 412-641-1466

Contact
Office: Magee-Womens Hospital
300 Halket St, 1644
Pittsburgh, PA 15213
 
Phone: 412-641-1466
Fax: 412-641-1132
E-mail: dthull@magee.edu
Education and Training
Education
BA, Biology, Russell Sage College, 1986
MS, Genetics and Genetic Counseling, University of Pittsburgh, GSPH, 1989
Research Interest
My primary research interest is the use of hereditary cancer registries as a means to facilitate research in cancer prevention, screening and personalized care for families with hereditary cancer predisposition.
Clinical Interest
Telemedicine Genetic Counseling. Use of telemedicine as a means to provide counseling to patients and families in outlying areas that do not have access to genetic counseling and risk assessment services.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Engel N, Gordon P, Thull DL, Dudley B, Herstine J, Jankowitz RC, Zorn KK. A Multidisciplinary Clinic for Individualizing Management of Patients at Increased Risk for Breast and Gynecologic Cancer. Family Cancer. 2012; 3: 419-27.
Serap E, Thull DL, Soran A. Editorial: Partner and Localizer of BRCA-2 (PALB-2) Mutation Analysis Is Rapidly Being Adopted into Clinical Practice. Journal of Breast Health. 2014; 10: 189.
Mas-Moya J, Dudley B, Brand RE, Thull D, Bahar N, Nikiforova MN, Pai RK. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. Human Pathology. 2015; 46(11): 1616-25.
Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai PK. Germline MLH1 Mutations are Frequently Identified in Lynch Syndrome Patients with Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2. Immunohistochemical Expression. American Journal of Surgical Pathology. 2015; 39(8): 1114-20.
Silvestri V, Barowdale D, Mulligan AM, Thull DL. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research. 2016; 18(1): 15.